Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 4/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | HRH1 | P35367 | 1/20 | 0.36 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16975161 | 0.86 | CA2 (0.40) | CA2MAPK1CA1CHRM1AKR1A1 | |
| SCHEMBL8927877 | 0.86 | CA2 (0.54) | CA2MAPK1CA1TDP1TSHR | |
| SCHEMBL1983515 | 0.86 | CA2 (0.54) | CA2MAPK1CA1TDP1CYP3A4 | |
| SCHEMBL7765839 | 0.85 | CHRM1 (0.42) | CA2MAPK1CA1CHRM1AKR1A1 | |
| SCHEMBL5483393 | 0.83 | CA2 (0.42) | CA2TSHRALDH1A1 | |
| SCHEMBL10583487 | 0.83 | CA2 (0.42) | CA2MAPK1CA1 | |
| SCHEMBL10456170 | 0.81 | CHRM1 (0.39) | CA2MAPK1CA1CHRM1AKR1A1 | |
| SCHEMBL16098245 | 0.81 | CA2 (0.43) | CA2MAPK1CA1ALDH1A1CES2 | |
| SCHEMBL7904735 | 0.81 | CA2 (0.43) | CA2MAPK1CA1CHRM1AKR1A1 | |
| SCHEMBL10535669 | 0.80 | CA2 (0.39) | CA2MAPK1CA1CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0236215-B1 | 2,2'-DIFLUORO-4-ALKOXY-4'-HYDROXY BIPHENYLS AND THEIR DERIVATIVES, THEIR PRODUCTION PROCESS AND THEIR USE IN LIQUID CRYSTAL DISPLAY DEVICES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1990-01-10 | — | — | EP | claimed |
| CN-115309734-A | Multi-source heterogeneous data processing method for transformer substation | 广东电网有限责任公司东莞供电局 | 2022-11-08 | — | — | CN | disclosed |
| EP-2958883-A1 | CYCLOHEXENONE COMPOSITIONS AND PROCESS FOR MAKING THEREOF | Golden Biotechnology Corporation (US) | 2015-12-30 | — | — | EP | disclosed |
| WO-2014130618-A1 | CYCLOHEXENONE COMPOSITIONS AND PROCESS FOR MAKING THEREOF | GOLDEN BIOTECHNOLOGY CORPORATION (US) | 2014-08-28 | — | — | WO | disclosed |
| US-7074927-B2 | Heterocyclic amines having central nervous system activity | PHARMACIA & UPJOHN COMPANY (US) | 2006-07-11 | — | — | US | disclosed |
| US-20050107378-A1 | Heterocyclic amines having central nervous system activity | ROMERO ARTHUR G (US) | 2005-05-19 | — | — | US | disclosed |
| US-5077287-A | Treating infectious diseases in man and animals | ELI LILLY AND COMPANY (US) | 1991-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050107378-A1 | Heterocyclic amines having central nervous system activity | CNR1, CNR2, NPY2R | CA2 1393/4885MAPK1 618/4885CA1 3238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.